Precision, integrative medicine for pain management in sickle cell disease.
Precision, integrative medicine for pain management in sickle cell disease.
复制标题
DOI：
10.3389/fpain.2023.1279361
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
Sickle cell disease (SCD) is a prevalent and complex inherited pain disorder that can manifest as acute vaso-occlusive crises (VOC) and/or chronic pain. Despite their known risks, opioids are often prescribed routinely and indiscriminately in managing SCD pain, because it is so often severe and debilitating. Integrative medicine strategies, particularly non-opioid therapies, hold promise in safe and effective management of SCD pain. However, the lack of evidence-based methods for managing SCD pain hinders the widespread implementation of non-opioid therapies. In this review, we acknowledge that implementing personalized pain treatment strategies in SCD, which is a guideline-recommended strategy, is currently fraught with limitations. The full implementation of pharmacological and biobehavioral pain approaches targeting mechanistic pain pathways faces challenges due to limited knowledge and limited financial and personnel support. We recommend personalized medicine, pharmacogenomics, and integrative medicine as aspirational strategies for improving pain care in SCD. As an organizing model that is a comprehensive framework for classifying pain subphenotypes and mechanisms in SCD, and for guiding selection of specific strategies, we present evidence updating pain research pioneer Richard Melzack’s neuromatrix theory of pain. We advocate for using the updated neuromatrix model to subphenotype individuals with SCD, to better select personalized multimodal treatment strategies, and to identify research gaps fruitful for exploration. We present a fairly complete list of currently used pharmacologic and non-pharmacologic SCD pain therapies, classified by their mechanism of action and by their hypothesized targets in the updated neuromatrix model.
登录
查看更多内容
影响因子：
2.4
作者：
Plonski, Krystal S.
通讯作者：
Plonski, Krystal S.
影响因子：
4
作者：
Campbell, Claudia M.;Moscou-Jackson, Gyasi;Haythornthwaite, Jennifer A.
通讯作者：
Haythornthwaite, Jennifer A.
影响因子：
1.7
作者：
Badawy SM;Abebe KZ;Reichman CA;Checo G;Hamm ME;Stinson J;Lalloo C;Carroll P;Saraf SL;Gordeuk VR;Desai P;Shah N;Liles D;Trimnell C;Jonassaint CR
通讯作者：
Jonassaint CR
影响因子：
12.8
作者：
Brandow, Amanda M.;Stucky, Cheryl L.;Panepinto, Julie A.
通讯作者：
Panepinto, Julie A.
影响因子：
20.3
作者：
Bartolucci, Pablo;El Murr, Tony;Godeau, Bertrand
通讯作者：
Godeau, Bertrand